---
schema_version: "secwatch.filing_event.v1"
accession: "0001156039-25-000111"
form_type: "8-K"
ticker: "ELV"
cik: "0001156039"
company_name: "Elevance Health, Inc."
filed_at: "2025-07-17T23:59:59+00:00"
generated_at: "2026-05-18T05:54:44.811185+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Elevance Health cuts FY2025 adjusted EPS guidance to ~$30 on elevated medical costs

## Summary
- Operating revenue $49.4B (+14.3% YoY); diluted EPS $7.72, adjusted diluted EPS $8.84.
- Benefit expense ratio 88.9% (+260 bps) reflecting higher medical costs in Medicaid and ACA.
- FY2025 GAAP EPS guidance ~$24.10; adjusted EPS guidance ~$30.00 (previously ~$35).
- Health Benefits segment operating gain $1.6B vs $2.1B prior year; margin 3.8% vs 5.8%.
- Returned $2.0B of capital to shareholders YTD; declared $1.71/quarter dividend payable 9/25/25.

## SEC filing metadata
- accession: 0001156039-25-000111
- form_type: 8-K
- ticker: ELV
- cik: 0001156039
- company_name: Elevance Health, Inc.
- filed_at: 2025-07-17T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1156039/000115603925000111/0001156039-25-000111-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1156039/000115603925000111/elv-20250717.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001156039-25-000111
- JSON: https://secwatch.observer/filing/0001156039-25-000111.json
- Plain text: https://secwatch.observer/filing/0001156039-25-000111.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.